Instant View: Reaction to new Novo Nordisk CEO, profit warning

In This Article: (Reuters) -Novo Nordisk on Tuesday appointed insider Mike Doustdar as its new chief executive after the Danish obesity drug maker cut its full year outlook for the second time in 2025, sending its shares tumbling. Here are some reactions from market analysts and investors: MARKUS…